Study held to see the effect of intake of Lavangchatuhasama powder in the management of Udarshool in children.

A Single arm clinical study to evaluate the effect of lavangchatuhasama churna in the management of Udarshool (Abdominal pain) in childern

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/029568

Enrollment

Registered

2020-12-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

Intervention1: Lavanchatuhsamchurna Churna : Powder of Lavanga, sheet jeerak, Nationals,shudhha Tankan in equal quantity advised to take along with madhu(honey) to be taken three times a day for the

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subject of age group from 3-12 years irrespective of gender. 2.History of frequent Abdominal Pain. 3. Patient having history of Symptoms of UDARSHOOL like Excessive crying , Udarstabdhata 4.Signs and Symptoms of Udarshool mentioned in Kashayap samhita and Modern texts. 5.The patients whose parents are ready to participate in the clinical trial by giving informed written consent.

Exclusion criteria

Exclusion criteria: 1.Udarshool associated with Jwar (fever), Chardi(Vomiting), Atisar (Diarrhoea), Pravahika (dysentery), Krimi (Worm infestation) etc. 2. Known Case Of any congenital anomalies . 3.Patient having Abodminal pain due to food allergies if any. 4.Patients who require surgical management. 5.Sever persistence abdominal pain.

Design outcomes

Primary

Measure	Time frame
Lavangchatuhsama churna is effective in the management of Udarshool (abdominal pain) in childern.Timepoint: 7 days study with 3 follow ups (0,3,5,7 days)	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactPrasad Maske

Dr D Y Patil College Of Ayurveda And Research Center

Dr.mosim2010@gmail.com8788746645

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026